BENGALURU: Honasa Consumer Ltd’s acquisition of a majority stake in Fluence Pharma marks more than its entry into nutraceuticals. It is also a clear signal that India’s beauty and personal care (BPC) ...

Fluence Energy has introduced a 10 MWh configuration for its Smartstack utility-scale battery energy storage system platform, expanding on its existing 7.5 MWh option. The new high-density system ...

Fluence Energy has increased the storage capacity of its Smartstack battery energy storage system, now scalable to 10 MWh. The 10-MWh system joins the company’s existing 7-MWh offering. As the latest ...

Honasa Consumer, the parent company of Mamaearth, has acquired a 58% stake in Fluence Pharma, a science-led nutraceuticals company, marking the beauty and personal care major’s first move into the ...

Honasa Consumer, the parent entity of digital-first beauty unicorn Mamaearth, has acquired a 58% stake in Mumbai-based hair therapy and nutraceuticals brand Fluence Pharma. While the companies did not ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.

Continuing its acquisition spree, Mamaearth parent Honasa Consumer’s board has approved a majority stake acquisition in nutraceuticals company Fluence Pharma, marking its entry into the fast-growing ...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year, following its purchase of ...

Beauty and personal care company Honasa Consumer Ltd will acquire 58% stake in Fluence Pharma, a science-backed nutraceuticals company, at an enterprise value of ₹135 crore. Honasa, which sells brands ...

Mamaearth parent Honasa Consumer has acquired a 58% stake in nutraceuticals company Fluence Pharma at an enterprise value of around Rs 135 crore. With this acquisition, the company is expanding into ...